Factors such as technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, rising geriatric population & growing number of surgeries, awareness initiatives by industry players, and government focus on critical care infrastructure & services are driving the growth of the hemodynamic monitoring systems market. In addition, growing demand for patient monitoring devices in non-hospital settings and the emerging economies (such as China, India, Brazil, and Mexico) are expected to offer lucrative growth opportunities for market players in the hemodynamic monitoring systems market. However, a risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market. Moreover, increasing pricing pressure on market players, limited patient awareness related to disease diagnosis, and dearth of skilled professionals are adversely impacting the growth of the market.
Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21684146
- Market Drivers
- Market Restraints
- Market Opportunity
- Market Challenges
Driver: Technological advancements in hemodynamic monitoring systems
Recent years have witnessed a growing preference for noninvasive technologies from traditionally accepted invasive techniques.
Emerging markets will offer potential growth opportunities for global players operating in the hemodynamic monitoring systems market in the coming years, mainly due to the increasing patient population across these countries, rising adoption of patient monitoring devices, growing awareness regarding cardiovascular diseases, and improving healthcare infrastructure. Moreover, emerging countries have registered a sustained increase in surgical procedures during the past decade, driven by the growing target patient population, a growing number of CVD-related deaths, and rising medical tourism.
The APAC region comprising Japan, China, India, and Rest of Asia Pacific offers high-growth opportunities for players in the hemodynamic monitoring systems market. Some of the factors driving market growth in the APAC region are Japan’s growing healthcare industry; extensive government reimbursement coverage for critical cardiac procedures; improving healthcare infrastructure in India and China; high diabetes prevalence in Vietnam, Singapore, Malaysia, China, and India; and government initiatives in Australia and Singapore.
Key Market Players
Edwards Lifesciences (US), PULSION Medical Systems SE (Germany), LiDCO Group (UK), Deltex Medical (UK), ICU Medical (US), CNSYSTEMS MEDIZINTECHNIK GMBH(Austria), CareTaker Medical (US), OSYPKA MEDICAL GMBH (Germany), Cheetah Medical (US), Uscom (Australia), NI Medical (Israel)
- In March 2018, Edwards Lifesciences launched Acumen Hypotension Prediction Index (HPI) software in the US.
- In February 2018, LiDCO Group had an agreement with Spacelabs Healthcare SAS to distribute LiDCO products in France.
- In January 2018, Koninklijke Philips launched IntelliVue X3.
- In January 2018, The University Teaching Hospital (US) incorporated Deltex’s Oesophageal Doppler Monitoring (ODM) system.
Inquiry before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=21684146